InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Witte Owen N., Director. Director active across 2 companies, notably Allogene Therapeutics, Inc.. Aggregated, 8 disclosures have been logged. Breakdown: 0 buy · 6 sells. Total volume traded: €846k. Activity tracked since 9 June 2021. The latest transaction was disclosed on 13 June 2023 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Owen N. Witte is a Director at Allogene Therapeutics, Inc., a company specializing in gene therapies. In his role, he contributes to the strategy and governance of the firm, ensuring that Allogene meets industry standards and shareholder expectations.